Organovo Holdings Inc (ONVO) Given Average Rating of “Strong Buy” by Analysts
Shares of Organovo Holdings Inc (NASDAQ:ONVO) have been given a consensus broker rating score of 1.33 (Strong Buy) from the three analysts that provide coverage for the company, Zacks Investment Research reports. One research analyst has rated the stock with a buy rating and two have given a strong buy rating to the company. Organovo Holdings’ rating score has declined by 6.4% in the last three months as a result of a number of analysts’ ratings changes.
Analysts have set a 1-year consensus price objective of $4.67 for the company and are expecting that the company will post ($0.11) earnings per share for the current quarter, according to Zacks. Zacks has also given Organovo Holdings an industry rank of 102 out of 265 based on the ratings given to its competitors.
A number of research analysts have commented on ONVO shares. Zacks Investment Research lowered Organovo Holdings from a “strong-buy” rating to a “hold” rating in a research report on Thursday, January 5th. Jefferies Group LLC reiterated a “buy” rating and issued a $4.50 price objective on shares of Organovo Holdings in a research report on Thursday, March 16th. Finally, Raymond James Financial, Inc. started coverage on Organovo Holdings in a research report on Wednesday, January 25th. They issued an “outperform” rating and a $5.00 price objective on the stock.
In other news, CEO Keith Murphy sold 25,000 shares of the stock in a transaction on Thursday, February 9th. The stock was sold at an average price of $3.68, for a total value of $92,000.00. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.
Hedge funds and other institutional investors have recently bought and sold shares of the stock. WFG Advisors LP increased its position in Organovo Holdings by 138.6% in the fourth quarter. WFG Advisors LP now owns 4,772 shares of the company’s stock worth $490,000 after buying an additional 2,772 shares during the period. Bessemer Group Inc. bought a new position in Organovo Holdings during the fourth quarter worth $102,000. Tudor Investment Corp Et Al increased its position in Organovo Holdings by 44.0% in the fourth quarter. Tudor Investment Corp Et Al now owns 31,035 shares of the company’s stock worth $105,000 after buying an additional 9,482 shares during the period. Private Advisor Group LLC increased its position in Organovo Holdings by 79.1% in the fourth quarter. Private Advisor Group LLC now owns 32,144 shares of the company’s stock worth $118,000 after buying an additional 14,194 shares during the period. Finally, Ladenburg Thalmann Financial Services Inc. increased its position in Organovo Holdings by 374.8% in the fourth quarter. Ladenburg Thalmann Financial Services Inc. now owns 49,975 shares of the company’s stock worth $169,000 after buying an additional 39,450 shares during the period.
TRADEMARK VIOLATION WARNING: “Organovo Holdings Inc (ONVO) Given Average Rating of “Strong Buy” by Analysts” was originally published by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The original version of this piece can be accessed at https://www.watchlistnews.com/organovo-holdings-inc-onvo-given-average-rating-of-strong-buy-by-analysts/1205938.html.
Shares of Organovo Holdings (NASDAQ:ONVO) traded up 2.29% during mid-day trading on Monday, reaching $2.68. The company’s stock had a trading volume of 711,360 shares. Organovo Holdings has a 12 month low of $2.41 and a 12 month high of $4.99. The company has a 50 day moving average of $2.98 and a 200-day moving average of $3.27.
Organovo Holdings (NASDAQ:ONVO) last announced its quarterly earnings data on Thursday, February 9th. The company reported ($0.09) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.10) by $0.01. The firm earned $1.15 million during the quarter, compared to the consensus estimate of $1.40 million. The company’s revenue for the quarter was up 248.5% on a year-over-year basis. On average, equities research analysts predict that Organovo Holdings will post ($0.40) EPS for the current year.
Organovo Holdings Company Profile
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Organovo Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo Holdings Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.